Communications of the ACM
Biological Sensors Are the Future of Personalized Medicine
Peter Ghazal is Professor of Molecular Genetics and Biomedicine, and head of the Division of Pathway Medicine, at the University of Edinburgh Medical School.
European Pharmaceutical Review Events
Madrid recently hosted the International Symposium on Research in Grid/Nano/Bio/Medical Informatics (Bioinforsalud 2009). Organized by ACTION-Grid, Bioinforsalud 2009 gave 20 scientists from around the world an opportunity to discuss their views on nanotechnology and the personalization of medicine. Peter Ghazal, chair of Edinburgh University's Department of Molecular Genetics and Biomedicine, said biological sensors could be used to detect infections and to devise personalized treatments. In order to treat patients with a certain drug, patients would need to have their own profile.
Martin Fritts of U.S. National Cancer Institute's Nanotechnology Characterization Lab said he is working to accelerate the use of nanotechnology concepts to treat cancer in clinical research. Informatics is important for knowledge discovery and transfer in clinical research, he said. Fritts added that researchers would need to understand how nanoparticles interact with their environment at the molecular level for nanomedicine-based treatments and diagnoses to be a success.
ACTION-Grid is funded by the European Commission, and encourages cooperation on biomedical informatics, grid technologies, and nanotechnology by scientists in Latin America, the Balkans, and North Africa.
From Universidad Politecnica de Madrid
View Full Article
Abstracts Copyright © 2009 Information Inc., Bethesda, Maryland, USA 
No entries found